A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
Article in EBioMedicine (March 2024)
The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.
Article in EBioMedicine (March 2024)
Preprint in bioRxiv (September 2023)
Article in Current Oncology Reports (August 2023)